Vallon Pharmaceuticals, Inc.
Vallon Pharmaceuticals, Inc. VLON Peers
See (VLON) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VLON | $0.40 | -13.04% | 0 | -0.03 | -$15.36 | N/A |
| VRTX | $448.40 | +1.45% | 115.1B | -117.08 | -$3.83 | N/A |
| REGN | $513.58 | +0.93% | 54.5B | 13.06 | $39.32 | +0.34% |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $312.32 | +1.17% | 40.7B | -149.44 | -$2.09 | N/A |
| ARGX | $537.92 | -0.52% | 32.8B | 32.78 | $16.41 | N/A |
| BNTX | $104.40 | -0.54% | 25.1B | -28.45 | -$3.67 | N/A |
| BGNE | $184.71 | +0.49% | 20.2B | -22.55 | -$8.19 | N/A |
| RPRX | $34.91 | +1.01% | 19.6B | 14.25 | $2.45 | +2.46% |
| DNA-WT | $0.27 | -2.76% | 18.7B | N/A | N/A | N/A |
Stock Comparison
VLON vs VRTX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, VRTX has a market cap of 115.1B. Regarding current trading prices, VLON is priced at $0.40, while VRTX trades at $448.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas VRTX's P/E ratio is -117.08. In terms of profitability, VLON's ROE is +0.00%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, VLON is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs REGN Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, REGN has a market cap of 54.5B. Regarding current trading prices, VLON is priced at $0.40, while REGN trades at $513.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas REGN's P/E ratio is 13.06. In terms of profitability, VLON's ROE is +0.00%, compared to REGN's ROE of +0.15%. Regarding short-term risk, VLON is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs SGEN Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, VLON is priced at $0.40, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas SGEN's P/E ratio is -57.19. In terms of profitability, VLON's ROE is +0.00%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, VLON is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ALNY Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ALNY has a market cap of 40.7B. Regarding current trading prices, VLON is priced at $0.40, while ALNY trades at $312.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ALNY's P/E ratio is -149.44. In terms of profitability, VLON's ROE is +0.00%, compared to ALNY's ROE of -5.09%. Regarding short-term risk, VLON is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ARGX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ARGX has a market cap of 32.8B. Regarding current trading prices, VLON is priced at $0.40, while ARGX trades at $537.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ARGX's P/E ratio is 32.78. In terms of profitability, VLON's ROE is +0.00%, compared to ARGX's ROE of +0.23%. Regarding short-term risk, VLON is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs BNTX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, BNTX has a market cap of 25.1B. Regarding current trading prices, VLON is priced at $0.40, while BNTX trades at $104.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas BNTX's P/E ratio is -28.45. In terms of profitability, VLON's ROE is +0.00%, compared to BNTX's ROE of -0.04%. Regarding short-term risk, VLON is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs BGNE Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, VLON is priced at $0.40, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas BGNE's P/E ratio is -22.55. In terms of profitability, VLON's ROE is +0.00%, compared to BGNE's ROE of -0.12%. Regarding short-term risk, VLON is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RPRX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RPRX has a market cap of 19.6B. Regarding current trading prices, VLON is priced at $0.40, while RPRX trades at $34.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RPRX's P/E ratio is 14.25. In terms of profitability, VLON's ROE is +0.00%, compared to RPRX's ROE of +0.16%. Regarding short-term risk, VLON is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs DNA-WT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, VLON is priced at $0.40, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, VLON's ROE is +0.00%, compared to DNA-WT's ROE of -0.63%. Regarding short-term risk, VLON is more volatile compared to DNA-WT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs SMMT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, SMMT has a market cap of 15B. Regarding current trading prices, VLON is priced at $0.40, while SMMT trades at $20.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas SMMT's P/E ratio is -59.29. In terms of profitability, VLON's ROE is +0.00%, compared to SMMT's ROE of -0.70%. Regarding short-term risk, VLON is more volatile compared to SMMT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs GMAB Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, GMAB has a market cap of 13.4B. Regarding current trading prices, VLON is priced at $0.40, while GMAB trades at $21.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas GMAB's P/E ratio is 12.68. In terms of profitability, VLON's ROE is +0.00%, compared to GMAB's ROE of +0.26%. Regarding short-term risk, VLON is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs INCY Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, INCY has a market cap of 13.2B. Regarding current trading prices, VLON is priced at $0.40, while INCY trades at $68.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas INCY's P/E ratio is 341.35. In terms of profitability, VLON's ROE is +0.00%, compared to INCY's ROE of +0.01%. Regarding short-term risk, VLON is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs UTHR Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, UTHR has a market cap of 13.2B. Regarding current trading prices, VLON is priced at $0.40, while UTHR trades at $291.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas UTHR's P/E ratio is 11.62. In terms of profitability, VLON's ROE is +0.00%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, VLON is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs KRTX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, VLON is priced at $0.40, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas KRTX's P/E ratio is -28.09. In terms of profitability, VLON's ROE is +0.00%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, VLON is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs EXEL Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, EXEL has a market cap of 11.1B. Regarding current trading prices, VLON is priced at $0.40, while EXEL trades at $40.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas EXEL's P/E ratio is 18.60. In terms of profitability, VLON's ROE is +0.00%, compared to EXEL's ROE of +0.29%. Regarding short-term risk, VLON is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs BMRN Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, BMRN has a market cap of 10.6B. Regarding current trading prices, VLON is priced at $0.40, while BMRN trades at $55.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas BMRN's P/E ratio is 20.46. In terms of profitability, VLON's ROE is +0.00%, compared to BMRN's ROE of +0.09%. Regarding short-term risk, VLON is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ASND Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ASND has a market cap of 10.3B. Regarding current trading prices, VLON is priced at $0.40, while ASND trades at $170.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ASND's P/E ratio is -25.56. In terms of profitability, VLON's ROE is +0.00%, compared to ASND's ROE of +1.91%. Regarding short-term risk, VLON is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MRNA Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MRNA has a market cap of 9.8B. Regarding current trading prices, VLON is priced at $0.40, while MRNA trades at $25.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MRNA's P/E ratio is -2.91. In terms of profitability, VLON's ROE is +0.00%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, VLON is more volatile compared to MRNA. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RXDX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, VLON is priced at $0.40, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RXDX's P/E ratio is -56.47. In terms of profitability, VLON's ROE is +0.00%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, VLON is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs IMGN Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, VLON is priced at $0.40, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas IMGN's P/E ratio is -111.55. In terms of profitability, VLON's ROE is +0.00%, compared to IMGN's ROE of -1.43%. Regarding short-term risk, VLON is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs BPMC Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, BPMC has a market cap of 8.3B. Regarding current trading prices, VLON is priced at $0.40, while BPMC trades at $128.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas BPMC's P/E ratio is -51.04. In terms of profitability, VLON's ROE is +0.00%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, VLON is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs CERE Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, VLON is priced at $0.40, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas CERE's P/E ratio is -16.47. In terms of profitability, VLON's ROE is +0.00%, compared to CERE's ROE of -0.43%. Regarding short-term risk, VLON is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs TECH Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, TECH has a market cap of 7.9B. Regarding current trading prices, VLON is priced at $0.40, while TECH trades at $50.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas TECH's P/E ratio is 60.40. In terms of profitability, VLON's ROE is +0.00%, compared to TECH's ROE of +0.06%. Regarding short-term risk, VLON is more volatile compared to TECH. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ROIVW Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ROIVW has a market cap of 7.8B. Regarding current trading prices, VLON is priced at $0.40, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, VLON's ROE is +0.00%, compared to ROIVW's ROE of -0.03%. Regarding short-term risk, VLON is more volatile compared to ROIVW. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ROIV Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ROIV has a market cap of 7.8B. Regarding current trading prices, VLON is priced at $0.40, while ROIV trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ROIV's P/E ratio is -15.25. In terms of profitability, VLON's ROE is +0.00%, compared to ROIV's ROE of -0.03%. Regarding short-term risk, VLON is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs VRNA Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, VRNA has a market cap of 7.7B. Regarding current trading prices, VLON is priced at $0.40, while VRNA trades at $90.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas VRNA's P/E ratio is -45.46. In terms of profitability, VLON's ROE is +0.00%, compared to VRNA's ROE of -0.90%. Regarding short-term risk, VLON is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs BBIO Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, BBIO has a market cap of 7.6B. Regarding current trading prices, VLON is priced at $0.40, while BBIO trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas BBIO's P/E ratio is -11.24. In terms of profitability, VLON's ROE is +0.00%, compared to BBIO's ROE of +0.49%. Regarding short-term risk, VLON is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs CORT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, CORT has a market cap of 7.6B. Regarding current trading prices, VLON is priced at $0.40, while CORT trades at $71.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas CORT's P/E ratio is 61.95. In terms of profitability, VLON's ROE is +0.00%, compared to CORT's ROE of +0.20%. Regarding short-term risk, VLON is more volatile compared to CORT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RVMD Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RVMD has a market cap of 7.4B. Regarding current trading prices, VLON is priced at $0.40, while RVMD trades at $39.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RVMD's P/E ratio is -9.96. In terms of profitability, VLON's ROE is +0.00%, compared to RVMD's ROE of -0.37%. Regarding short-term risk, VLON is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RETA Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, VLON is priced at $0.40, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RETA's P/E ratio is -66.29. In terms of profitability, VLON's ROE is +0.00%, compared to RETA's ROE of +0.47%. Regarding short-term risk, VLON is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs JAZZ Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, JAZZ has a market cap of 6.5B. Regarding current trading prices, VLON is priced at $0.40, while JAZZ trades at $108.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas JAZZ's P/E ratio is 14.71. In terms of profitability, VLON's ROE is +0.00%, compared to JAZZ's ROE of +0.12%. Regarding short-term risk, VLON is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs HALO Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, HALO has a market cap of 6.5B. Regarding current trading prices, VLON is priced at $0.40, while HALO trades at $53.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas HALO's P/E ratio is 14.14. In terms of profitability, VLON's ROE is +0.00%, compared to HALO's ROE of +1.22%. Regarding short-term risk, VLON is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MDGL Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MDGL has a market cap of 6.3B. Regarding current trading prices, VLON is priced at $0.40, while MDGL trades at $282.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MDGL's P/E ratio is -15.84. In terms of profitability, VLON's ROE is +0.00%, compared to MDGL's ROE of -0.51%. Regarding short-term risk, VLON is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs IONS Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, IONS has a market cap of 5.9B. Regarding current trading prices, VLON is priced at $0.40, while IONS trades at $37.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas IONS's P/E ratio is -12.38. In terms of profitability, VLON's ROE is +0.00%, compared to IONS's ROE of -0.92%. Regarding short-term risk, VLON is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs TLX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, TLX has a market cap of 5.7B. Regarding current trading prices, VLON is priced at $0.40, while TLX trades at $16.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas TLX's P/E ratio is 188.44. In terms of profitability, VLON's ROE is +0.00%, compared to TLX's ROE of +0.14%. Regarding short-term risk, VLON is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs TGTX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, TGTX has a market cap of 5.6B. Regarding current trading prices, VLON is priced at $0.40, while TGTX trades at $35.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas TGTX's P/E ratio is 140.66. In terms of profitability, VLON's ROE is +0.00%, compared to TGTX's ROE of +0.19%. Regarding short-term risk, VLON is more volatile compared to TGTX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ABCM Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, VLON is priced at $0.40, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, VLON's ROE is +0.00%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, VLON is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ISEE Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, VLON is priced at $0.40, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ISEE's P/E ratio is -22.44. In terms of profitability, VLON's ROE is +0.00%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, VLON is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs AMRN Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, AMRN has a market cap of 5.5B. Regarding current trading prices, VLON is priced at $0.40, while AMRN trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas AMRN's P/E ratio is -3.03. In terms of profitability, VLON's ROE is +0.00%, compared to AMRN's ROE of -0.17%. Regarding short-term risk, VLON is more volatile compared to AMRN. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs NUVL Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, NUVL has a market cap of 5.4B. Regarding current trading prices, VLON is priced at $0.40, while NUVL trades at $75.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas NUVL's P/E ratio is -17.52. In terms of profitability, VLON's ROE is +0.00%, compared to NUVL's ROE of -0.31%. Regarding short-term risk, VLON is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs AXSM Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, AXSM has a market cap of 5.1B. Regarding current trading prices, VLON is priced at $0.40, while AXSM trades at $102.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas AXSM's P/E ratio is -17.83. In terms of profitability, VLON's ROE is +0.00%, compared to AXSM's ROE of -3.64%. Regarding short-term risk, VLON is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ALKS Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ALKS has a market cap of 4.8B. Regarding current trading prices, VLON is priced at $0.40, while ALKS trades at $29.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ALKS's P/E ratio is 13.97. In terms of profitability, VLON's ROE is +0.00%, compared to ALKS's ROE of +0.25%. Regarding short-term risk, VLON is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ALPN Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, VLON is priced at $0.40, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ALPN's P/E ratio is -101.52. In terms of profitability, VLON's ROE is +0.00%, compared to ALPN's ROE of -0.04%. Regarding short-term risk, VLON is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs AKRO Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, AKRO has a market cap of 4.4B. Regarding current trading prices, VLON is priced at $0.40, while AKRO trades at $54.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas AKRO's P/E ratio is -14.64. In terms of profitability, VLON's ROE is +0.00%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, VLON is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ADMA Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ADMA has a market cap of 4.3B. Regarding current trading prices, VLON is priced at $0.40, while ADMA trades at $18.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ADMA's P/E ratio is 21.58. In terms of profitability, VLON's ROE is +0.00%, compared to ADMA's ROE of +0.72%. Regarding short-term risk, VLON is more volatile compared to ADMA. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs PCVX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, PCVX has a market cap of 4.3B. Regarding current trading prices, VLON is priced at $0.40, while PCVX trades at $33.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas PCVX's P/E ratio is -8.37. In terms of profitability, VLON's ROE is +0.00%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, VLON is more volatile compared to PCVX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs OPT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, VLON is priced at $0.40, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas OPT's P/E ratio is -1.52. In terms of profitability, VLON's ROE is +0.00%, compared to OPT's ROE of +2.60%. Regarding short-term risk, VLON is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MRTX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, VLON is priced at $0.40, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MRTX's P/E ratio is -4.82. In terms of profitability, VLON's ROE is +0.00%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, VLON is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ZLAB Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ZLAB has a market cap of 4B. Regarding current trading prices, VLON is priced at $0.40, while ZLAB trades at $36.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ZLAB's P/E ratio is -14.77. In terms of profitability, VLON's ROE is +0.00%, compared to ZLAB's ROE of -0.33%. Regarding short-term risk, VLON is more volatile compared to ZLAB. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs SLNO Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, SLNO has a market cap of 4B. Regarding current trading prices, VLON is priced at $0.40, while SLNO trades at $79.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas SLNO's P/E ratio is -16.75. In terms of profitability, VLON's ROE is +0.00%, compared to SLNO's ROE of -0.78%. Regarding short-term risk, VLON is more volatile compared to SLNO. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs PTCT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, PTCT has a market cap of 4B. Regarding current trading prices, VLON is priced at $0.40, while PTCT trades at $50.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas PTCT's P/E ratio is 7.75. In terms of profitability, VLON's ROE is +0.00%, compared to PTCT's ROE of -0.72%. Regarding short-term risk, VLON is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MRUS Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MRUS has a market cap of 3.9B. Regarding current trading prices, VLON is priced at $0.40, while MRUS trades at $52.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MRUS's P/E ratio is -12.64. In terms of profitability, VLON's ROE is +0.00%, compared to MRUS's ROE of -0.41%. Regarding short-term risk, VLON is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RYTM Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RYTM has a market cap of 3.9B. Regarding current trading prices, VLON is priced at $0.40, while RYTM trades at $61.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RYTM's P/E ratio is -21.96. In terms of profitability, VLON's ROE is +0.00%, compared to RYTM's ROE of -1.80%. Regarding short-term risk, VLON is more volatile compared to RYTM. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs CYTK Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, CYTK has a market cap of 3.9B. Regarding current trading prices, VLON is priced at $0.40, while CYTK trades at $32.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas CYTK's P/E ratio is -6.19. In terms of profitability, VLON's ROE is +0.00%, compared to CYTK's ROE of +8.01%. Regarding short-term risk, VLON is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ACAD Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ACAD has a market cap of 3.8B. Regarding current trading prices, VLON is priced at $0.40, while ACAD trades at $22.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ACAD's P/E ratio is 16.75. In terms of profitability, VLON's ROE is +0.00%, compared to ACAD's ROE of +0.35%. Regarding short-term risk, VLON is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs CRSP Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, CRSP has a market cap of 3.8B. Regarding current trading prices, VLON is priced at $0.40, while CRSP trades at $44.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas CRSP's P/E ratio is -9.90. In terms of profitability, VLON's ROE is +0.00%, compared to CRSP's ROE of -0.20%. Regarding short-term risk, VLON is more volatile compared to CRSP. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs KRYS Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, KRYS has a market cap of 3.8B. Regarding current trading prices, VLON is priced at $0.40, while KRYS trades at $132.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas KRYS's P/E ratio is 31.68. In terms of profitability, VLON's ROE is +0.00%, compared to KRYS's ROE of +0.14%. Regarding short-term risk, VLON is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RYZB Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, VLON is priced at $0.40, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RYZB's P/E ratio is -57.86. In terms of profitability, VLON's ROE is +0.00%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, VLON is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs CBAY Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, VLON is priced at $0.40, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas CBAY's P/E ratio is -32.81. In terms of profitability, VLON's ROE is +0.00%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, VLON is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RNA Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RNA has a market cap of 3.5B. Regarding current trading prices, VLON is priced at $0.40, while RNA trades at $29.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RNA's P/E ratio is -9.77. In terms of profitability, VLON's ROE is +0.00%, compared to RNA's ROE of -0.27%. Regarding short-term risk, VLON is more volatile compared to RNA. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RARE Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RARE has a market cap of 3.5B. Regarding current trading prices, VLON is priced at $0.40, while RARE trades at $37.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RARE's P/E ratio is -6.41. In terms of profitability, VLON's ROE is +0.00%, compared to RARE's ROE of -1.86%. Regarding short-term risk, VLON is more volatile compared to RARE. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs SWTX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, VLON is priced at $0.40, while SWTX trades at $46.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas SWTX's P/E ratio is -13.72. In terms of profitability, VLON's ROE is +0.00%, compared to SWTX's ROE of -0.51%. Regarding short-term risk, VLON is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ACLX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ACLX has a market cap of 3.5B. Regarding current trading prices, VLON is priced at $0.40, while ACLX trades at $63.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ACLX's P/E ratio is -21.34. In terms of profitability, VLON's ROE is +0.00%, compared to ACLX's ROE of -0.35%. Regarding short-term risk, VLON is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs SRRK Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, SRRK has a market cap of 3.4B. Regarding current trading prices, VLON is priced at $0.40, while SRRK trades at $36.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas SRRK's P/E ratio is -14.24. In terms of profitability, VLON's ROE is +0.00%, compared to SRRK's ROE of -1.18%. Regarding short-term risk, VLON is more volatile compared to SRRK. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs PTGX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, PTGX has a market cap of 3.3B. Regarding current trading prices, VLON is priced at $0.40, while PTGX trades at $53.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas PTGX's P/E ratio is 69.13. In terms of profitability, VLON's ROE is +0.00%, compared to PTGX's ROE of +0.09%. Regarding short-term risk, VLON is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs LEGN Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, LEGN has a market cap of 3.2B. Regarding current trading prices, VLON is priced at $0.40, while LEGN trades at $34.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas LEGN's P/E ratio is -29.57. In terms of profitability, VLON's ROE is +0.00%, compared to LEGN's ROE of -0.20%. Regarding short-term risk, VLON is more volatile compared to LEGN. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs AAPG Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, AAPG has a market cap of 3.1B. Regarding current trading prices, VLON is priced at $0.40, while AAPG trades at $35.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas AAPG's P/E ratio is -47.84. In terms of profitability, VLON's ROE is +0.00%, compared to AAPG's ROE of -2.50%. Regarding short-term risk, VLON is more volatile compared to AAPG. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs KYMR Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, KYMR has a market cap of 3B. Regarding current trading prices, VLON is priced at $0.40, while KYMR trades at $46.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas KYMR's P/E ratio is -14.93. In terms of profitability, VLON's ROE is +0.00%, compared to KYMR's ROE of -0.30%. Regarding short-term risk, VLON is more volatile compared to KYMR. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs VKTX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, VKTX has a market cap of 3B. Regarding current trading prices, VLON is priced at $0.40, while VKTX trades at $26.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas VKTX's P/E ratio is -22.66. In terms of profitability, VLON's ROE is +0.00%, compared to VKTX's ROE of -0.14%. Regarding short-term risk, VLON is more volatile compared to VKTX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MTSR Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MTSR has a market cap of 2.9B. Regarding current trading prices, VLON is priced at $0.40, while MTSR trades at $27.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MTSR's P/E ratio is -10.95. In terms of profitability, VLON's ROE is +0.00%, compared to MTSR's ROE of -0.63%. Regarding short-term risk, VLON is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MORF Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MORF has a market cap of 2.9B. Regarding current trading prices, VLON is priced at $0.40, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MORF's P/E ratio is -14.88. In terms of profitability, VLON's ROE is +0.00%, compared to MORF's ROE of -0.22%. Regarding short-term risk, VLON is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs CRNX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, CRNX has a market cap of 2.9B. Regarding current trading prices, VLON is priced at $0.40, while CRNX trades at $30.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas CRNX's P/E ratio is -8.03. In terms of profitability, VLON's ROE is +0.00%, compared to CRNX's ROE of -0.31%. Regarding short-term risk, VLON is more volatile compared to CRNX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MOR Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MOR has a market cap of 2.9B. Regarding current trading prices, VLON is priced at $0.40, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MOR's P/E ratio is -12.64. In terms of profitability, VLON's ROE is +0.00%, compared to MOR's ROE of +2.51%. Regarding short-term risk, VLON is more volatile compared to MOR. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs CPRX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, CPRX has a market cap of 2.8B. Regarding current trading prices, VLON is priced at $0.40, while CPRX trades at $22.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas CPRX's P/E ratio is 14.53. In terms of profitability, VLON's ROE is +0.00%, compared to CPRX's ROE of +0.28%. Regarding short-term risk, VLON is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MLTX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MLTX has a market cap of 2.8B. Regarding current trading prices, VLON is priced at $0.40, while MLTX trades at $43.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MLTX's P/E ratio is -18.91. In terms of profitability, VLON's ROE is +0.00%, compared to MLTX's ROE of -0.00%. Regarding short-term risk, VLON is more volatile compared to MLTX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs IMVT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, IMVT has a market cap of 2.7B. Regarding current trading prices, VLON is priced at $0.40, while IMVT trades at $15.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas IMVT's P/E ratio is -5.81. In terms of profitability, VLON's ROE is +0.00%, compared to IMVT's ROE of -0.81%. Regarding short-term risk, VLON is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs KDNY Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, KDNY has a market cap of 2.7B. Regarding current trading prices, VLON is priced at $0.40, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas KDNY's P/E ratio is -12.47. In terms of profitability, VLON's ROE is +0.00%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, VLON is more volatile compared to KDNY. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MYOV Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MYOV has a market cap of 2.6B. Regarding current trading prices, VLON is priced at $0.40, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MYOV's P/E ratio is -14.05. In terms of profitability, VLON's ROE is +0.00%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, VLON is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs MIRM Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, MIRM has a market cap of 2.5B. Regarding current trading prices, VLON is priced at $0.40, while MIRM trades at $50.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas MIRM's P/E ratio is -31.55. In terms of profitability, VLON's ROE is +0.00%, compared to MIRM's ROE of -0.34%. Regarding short-term risk, VLON is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs IBRX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, IBRX has a market cap of 2.5B. Regarding current trading prices, VLON is priced at $0.40, while IBRX trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas IBRX's P/E ratio is -4.98. In terms of profitability, VLON's ROE is +0.00%, compared to IBRX's ROE of +0.65%. Regarding short-term risk, VLON is more volatile compared to IBRX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs APGE Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, APGE has a market cap of 2.5B. Regarding current trading prices, VLON is priced at $0.40, while APGE trades at $41.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas APGE's P/E ratio is -11.41. In terms of profitability, VLON's ROE is +0.00%, compared to APGE's ROE of -0.19%. Regarding short-term risk, VLON is more volatile compared to APGE. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs XENE Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, XENE has a market cap of 2.4B. Regarding current trading prices, VLON is priced at $0.40, while XENE trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas XENE's P/E ratio is -9.91. In terms of profitability, VLON's ROE is +0.00%, compared to XENE's ROE of -0.32%. Regarding short-term risk, VLON is more volatile compared to XENE. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs PRVB Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, PRVB has a market cap of 2.4B. Regarding current trading prices, VLON is priced at $0.40, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas PRVB's P/E ratio is -16.43. In terms of profitability, VLON's ROE is +0.00%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, VLON is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs NAMSW Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, NAMSW has a market cap of 2.4B. Regarding current trading prices, VLON is priced at $0.40, while NAMSW trades at $9.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas NAMSW's P/E ratio is N/A. In terms of profitability, VLON's ROE is +0.00%, compared to NAMSW's ROE of -0.33%. Regarding short-term risk, VLON is more volatile compared to NAMSW. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs LBPH Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, LBPH has a market cap of 2.3B. Regarding current trading prices, VLON is priced at $0.40, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas LBPH's P/E ratio is -26.66. In terms of profitability, VLON's ROE is +0.00%, compared to LBPH's ROE of -0.33%. Regarding short-term risk, VLON is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs DICE Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, DICE has a market cap of 2.3B. Regarding current trading prices, VLON is priced at $0.40, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas DICE's P/E ratio is -21.91. In terms of profitability, VLON's ROE is +0.00%, compared to DICE's ROE of +0.56%. Regarding short-term risk, VLON is more volatile compared to DICE. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs APLS Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, APLS has a market cap of 2.2B. Regarding current trading prices, VLON is priced at $0.40, while APLS trades at $17.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas APLS's P/E ratio is -9.87. In terms of profitability, VLON's ROE is +0.00%, compared to APLS's ROE of -1.00%. Regarding short-term risk, VLON is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs LGND Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, LGND has a market cap of 2.2B. Regarding current trading prices, VLON is priced at $0.40, while LGND trades at $114.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas LGND's P/E ratio is -15.73. In terms of profitability, VLON's ROE is +0.00%, compared to LGND's ROE of -0.16%. Regarding short-term risk, VLON is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs ARWR Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, ARWR has a market cap of 2.2B. Regarding current trading prices, VLON is priced at $0.40, while ARWR trades at $15.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas ARWR's P/E ratio is -12.60. In terms of profitability, VLON's ROE is +0.00%, compared to ARWR's ROE of -0.47%. Regarding short-term risk, VLON is more volatile compared to ARWR. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs CALT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, CALT has a market cap of 2.1B. Regarding current trading prices, VLON is priced at $0.40, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas CALT's P/E ratio is -22.73. In terms of profitability, VLON's ROE is +0.00%, compared to CALT's ROE of -1.67%. Regarding short-term risk, VLON is more volatile compared to CALT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs VCEL Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, VCEL has a market cap of 2.1B. Regarding current trading prices, VLON is priced at $0.40, while VCEL trades at $41.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas VCEL's P/E ratio is 835.60. In terms of profitability, VLON's ROE is +0.00%, compared to VCEL's ROE of +0.01%. Regarding short-term risk, VLON is more volatile compared to VCEL. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs VCYT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, VCYT has a market cap of 2.1B. Regarding current trading prices, VLON is priced at $0.40, while VCYT trades at $26.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas VCYT's P/E ratio is 63.86. In terms of profitability, VLON's ROE is +0.00%, compared to VCYT's ROE of +0.03%. Regarding short-term risk, VLON is more volatile compared to VCYT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs BCRX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, BCRX has a market cap of 2.1B. Regarding current trading prices, VLON is priced at $0.40, while BCRX trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas BCRX's P/E ratio is -38.31. In terms of profitability, VLON's ROE is +0.00%, compared to BCRX's ROE of +0.11%. Regarding short-term risk, VLON is more volatile compared to BCRX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs AGIO Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, AGIO has a market cap of 2.1B. Regarding current trading prices, VLON is priced at $0.40, while AGIO trades at $35.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas AGIO's P/E ratio is 3.08. In terms of profitability, VLON's ROE is +0.00%, compared to AGIO's ROE of +0.50%. Regarding short-term risk, VLON is more volatile compared to AGIO. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs DNLI Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, DNLI has a market cap of 2B. Regarding current trading prices, VLON is priced at $0.40, while DNLI trades at $14.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas DNLI's P/E ratio is -5.38. In terms of profitability, VLON's ROE is +0.00%, compared to DNLI's ROE of -0.36%. Regarding short-term risk, VLON is more volatile compared to DNLI. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs NAMS Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, NAMS has a market cap of 2B. Regarding current trading prices, VLON is priced at $0.40, while NAMS trades at $18.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas NAMS's P/E ratio is -9.89. In terms of profitability, VLON's ROE is +0.00%, compared to NAMS's ROE of -0.33%. Regarding short-term risk, VLON is more volatile compared to NAMS. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs RXRX Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, RXRX has a market cap of 2B. Regarding current trading prices, VLON is priced at $0.40, while RXRX trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas RXRX's P/E ratio is -2.84. In terms of profitability, VLON's ROE is +0.00%, compared to RXRX's ROE of -0.75%. Regarding short-term risk, VLON is more volatile compared to RXRX. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs SRPT Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, SRPT has a market cap of 2B. Regarding current trading prices, VLON is priced at $0.40, while SRPT trades at $20.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas SRPT's P/E ratio is -7.87. In terms of profitability, VLON's ROE is +0.00%, compared to SRPT's ROE of -0.20%. Regarding short-term risk, VLON is more volatile compared to SRPT. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.
VLON vs KNSA Comparison
VLON plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VLON stands at 0. In comparison, KNSA has a market cap of 2B. Regarding current trading prices, VLON is priced at $0.40, while KNSA trades at $27.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VLON currently has a P/E ratio of -0.03, whereas KNSA's P/E ratio is -116.37. In terms of profitability, VLON's ROE is +0.00%, compared to KNSA's ROE of -0.04%. Regarding short-term risk, VLON is more volatile compared to KNSA. This indicates potentially higher risk in terms of short-term price fluctuations for VLON.